SCHEMBL24258285

SCHEMBL24258285

FC(F)(P)c1ccc(CNC2CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 5/20 0.50
▸ ACHE P22303 5/20 0.50
▸ BACE1 P56817 5/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ HRH3 Q9Y5N1 3/20 0.49
▸ TEAD1 P28347 1/20 0.47
▸ POLB P06746 1/20 0.46
▸ HDAC1 Q13547 1/20 0.43
▸ GRIN2B Q13224 1/20 0.42
▸ KDM1A O60341 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ JAK2 O60674 1/20 0.39
▸ JAK1 P23458 1/20 0.39
▸ TYK2 P29597 1/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ PHGDH O43175 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5556152 0.85 BCHE (0.64) BCHEACHEBACE1MEN1RAB9A
Hydrochloric Acid SCHEMBL218521 0.84 BCHE (0.62) BCHEACHEBACE1MEN1RAB9A
SCHEMBL21729631 0.82 ACHE (0.50) BCHEACHEBACE1MEN1RAB9A
SCHEMBL10073807 0.80 MEN1 (0.69) BCHEACHEBACE1MEN1RAB9A
SCHEMBL23545594 0.79 TEAD1 (0.48) BCHEACHEBACE1MEN1RAB9A
SCHEMBL19650799 0.79 BCHE (0.61) BCHEACHEBACE1MEN1RAB9A
SCHEMBL24258289 0.79 HRH3 (0.62) BCHEACHEBACE1MEN1RAB9A
SCHEMBL2730914 0.78 KDM1A (0.54) BCHEACHEBACE1MEN1RAB9A
SCHEMBL25683753 0.77 TEAD1 (0.46) BCHEACHEBACE1MEN1RAB9A
SCHEMBL22787428 0.76 KDM1A (0.47) BCHEACHEBACE1RAB9AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 — — EP disclosed
Send feedback